Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

IntroductionCombinations of immune checkpoint inhibitors (ICIs) and angiogenesis inhibitors (AIs) have been investigated for the treatment of several tumor types. Both ICIs and AIs may lead to cardiovascular adverse events, and their combination may potentially increase the risk for cardiovascular t...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Alessandro Inno, Antonello Veccia, Giorgio Madonia, Alvise Berti, Roberto Bortolotti, Lorena Incorvaia, Antonio Russo, Orazio Caffo, Stefania Gori
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	immune checkpoint inhibitors angiogenesis inhibitors multikinase inhibitors cardiovascular toxicity hypertension stroke
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1309100/full